Epidemiological and Prognostic Differences in Malignant Mesothelioma Between Eastern China and SEER Database
Cancer Science · 2026-11 · 117 (11) · 3146-3159
DOI: 10.1111/cas.70481 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, online erschienen am 21.07.2026. Verfasst von Ningning Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Mesothelioma, Malignant, Peritoneal Neoplasms, Mesothelioma, Lung Neoplasms. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Zhejiang Provincial Natural Science Foundation, National Natural Science Foundation of China, Medical and Health Science Project of Zhejiang Province.
Abstract (Originalsprache)
Eastern China malignant mesothelioma (MM) presents distinct features–younger age, female predominance, and moremalignant peritoneal mesothelioma (MPeM)–contrasting with the Western profile of older males with malignant pleural mesothelioma (MPM). Robust survival data for this population are still unavailable. This retrospective study included 253 MM patients from Zhejiang Cancer Hospital (2010–2024; 222 from Zhejiang Province, ZJ cohort) to update regional epidemiology and compare survival with the Surveillance, Epidemiology, and End Results program (SEER). The ZJ cohort exhibited a younger median age at diagnosis (58 vs. 74 years), a higher proportion of females (62% vs. 24%), and a higher prevalence of MPeM (54% vs. 11%) relative to the SEER cohort. Overall survival (OS) was significantly prolonged in the ZJ cohort (median OS: 22 vs. 10 months), with survival benefits consistently observed across sex, age, and MPM subgroups. Multivariate Cox analysis revealed age as the only consistent independent prognostic factor in both ZJ and SEER cohorts. Following propensity score matching to minimize confounding, the ZJ cohort maintained a significantly longer survival in MPM but exhibited worse outcome in MPeM relative to SEER. Collectively, this study not only updated epidemiologic features for MM in Eastern China but also reported the unique survival patterns, uncovering inter‐population heterogeneity. These findings emphasize the value of region‐specific prognostic evidence and the limitations of directly applying Western data to Asian populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China.
- Wenzhou Medical University, Wenzhou, Zhejiang, China.
- Zhejiang Hospital, Hangzhou, China.
ORCID-Profile: Zhongjian Chen
Förderung
- Zhejiang Provincial Natural Science Foundation
- National Natural Science Foundation of China
- Medical and Health Science Project of Zhejiang Province
Zitieren
APA
Li, N., Wang, R., Zhang, W., Shao, Z., Lin, H., Bao, G., Mao, W., & Chen, Z. (2026). Epidemiological and Prognostic Differences in Malignant Mesothelioma Between Eastern China and SEER Database. Cancer Science, 117(11), 3146-3159. https://doi.org/10.1111/cas.70481
Vancouver
Li N, Wang R, Zhang W, Shao Z, Lin H, Bao G, et al. Epidemiological and Prognostic Differences in Malignant Mesothelioma Between Eastern China and SEER Database. Cancer Science. 2026;117(11):3146-3159. doi:10.1111/cas.70481
BibTeX
@article{Li2026,
author = {Li, Ningning and Wang, Ruting and Zhang, Wenya and Shao, Zulei and Lin, Hongyu and Bao, Guanai and Mao, Weimin and Chen, Zhongjian},
title = {Epidemiological and Prognostic Differences in Malignant Mesothelioma Between Eastern China and SEER Database},
journal = {Cancer Science},
year = {2026},
volume = {117},
number = {11},
pages = {3146--3159},
doi = {10.1111/cas.70481}
}
EUVIMED